Eastman Q3 adjusted EPS $1.14 vs $2.26 YoY; guides FY adjusted EPS $5.40-$5.65

EASTMAN CHEMICAL CO

2025-Q3 EPS reported $3.18 vs consensus $1.18 ▲ beat (+170.5%)

Q3 sales revenue $2,202M (-11% YoY); GAAP EPS $0.40; adjusted EPS $1.14 vs $2.26 prior.
Operating cash flow $402M; inventory reduced ~$200M from Q2.
FY2025 adjusted EPS guided $5.40-$5.65; expects greater seasonal decline in Q4.
Segment weakness: Advanced Materials -7%, Fibers -24%, Chemical Intermediates -16%.
Cost cutting: >$75M net in 2025, ~$100M in 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.